The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
Open accessAbstract
Advanced glycation endproducts (AGE) contribute to kidney disease due to diabetes or aging by means of mesangial cell (MC) receptors, such as the receptor for AGE (RAGE), which promote oxidant-stress-dependent NF-kappaB activation and inflammatory gene expression. MC also express scavenger receptors SR-I and SR-II and AGE receptors 1, 2, and 3 (AGE-R1, -R2, and -R3), some of which are linked to AGE turnover. Because AGE-R1 expression is found suppressed in severe diabetic kidney disease, as other receptors increase, we investigated whether his molecule has a protective role against AGE-induced MC injury. A stable murine MC line overexpressing AGE-R1 (R1-MC) was generated, exhibiting a 1.8- to 2.7-fold increase in (125)I-AGE-specific binding, uptake, and degradation, compared with mock-MC. However, AGE-stimulated NF-kappaB activity and mitogen-activated protein kinase (MAPK) (p44/42) phosphorylation were found markedly suppressed in R1-MC. Additionally, AGE-stimulated macrophage chemotaxis protein 1 and RAGE overexpression were abolished in R1-MC. The effect of R1 on RAGE signaling was investigated after overexpressing RAGE in Chinese hamster ovary cells, which lack RAGE. AGE stimulation elicited NF-kappaB and MAPK activities in RAGE-Chinese hamster ovary cells; however, after cotransfection with R1, these responses were suppressed. Also, after silencing endogenous R1 in wild-type MC by R1 small interfering RNA, AGE-mediated MAPK/p44/42 activation exceeded by >2-fold that of mock-MC, consistent with loss of the activation-inhibitory properties of native AGE-R1. AGE-R1, although enhancing AGE removal, is also a distinct receptor in that it suppresses AGE-mediated MC inflammatory injury through negative regulation of RAGE, a previously uncharacterized pathway that may protect renal and other tissue injury due to diabetes and aging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The concentration of linoleic acid in blood lipids (578,579) or granulocytes (374) was not associated with CRP or IL-6 concentration”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
In the citing paper
“Data from an Italian study showed no association between a-linolenic acid in plasma fatty acids and several cytokines including IL-6 and TNF-a, but there was an inverse association with CRP (578)”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
In the citing paper
“Data from an Italian study showed no association between a-linolenic acid in plasma fatty acids and several cytokines including IL-6 and TNF-a, but there was an inverse association with CRP (578)”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
In the citing paper
“Ferrucci et al. (578) reported no association between arachidonic acid in plasma and CRP, TNF-a, IL-1b, IL-10 and sIL-6R concentrations, while there was an inverse association with IL-6 and IL-1ra concentrations and a positive association with TGF-b”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
In the citing paper
“In an elderly Italian population, plasma EPA was inversely associated with IL-6 concentration and positively associated with the concentrations of the anti-inflammatory cytokines IL-10 and TGFb (578) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
In the citing paper
“The concentration of a-linolenic acid in blood lipids (578,579,582) or granulocytes (374) was not associated with CRP or IL-6 concentration.”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
In the citing paper
“Ferrucci et al. (578) reported no association between arachidonic acid in plasma and CRP, TNF-a, IL-1b, IL-10 and sIL-6R concentrations, while there was an inverse association with IL-6 and IL-1ra concentrations and a positive association with TGF-b”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
In the citing paper
“Furthermore, plasma DHA was inversely associated with IL-6 and TNF-a concentrations and was also positively associated with the concentrations of IL-10 and TGF-b (578) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
In the citing paper
“Ferrucci et al. (578) reported no association between arachidonic acid in plasma and CRP, TNF-a, IL-1b, IL-10 and sIL-6R concentrations, while there was an inverse association with IL-6 and IL-1ra concentrations and a positive association with TGF-b”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [578]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,256
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
Suzuki, H. I., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,226
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,088
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Yan, S. D., Hofmann, M. A., Yan, S. F., Pischetsrieder, M., Stern, D. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 868
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Self-citationBrett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I. D., Mitsuhashi, T., Giordano, D., VanPatten, S., Lee, A., Al‐Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 550
Self-citationAdvanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE
Basta, G., Lazzerini, G., Massaro, M., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stern, D. M., Schmidt, A. M., & Caterina, R. D. (2002) · Circulation · doi:10.1161/hc0702.104183 · Cited by 544
Tanji, N., Markowitz, G. S., Fu, C., Kislinger, T., Taguchi, A., Pischetsrieder, M., Stern, D. M., Schmidt, A. M., & D’Agati, V. D. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1191656 · Cited by 485
Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara, H., Striker, L. J., Teichberg, S., Fuh, H., Li, Y. M., & Steffes, M. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11704 · Cited by 461
Self-citationTanaka, N., Yonekura, H., Yamagishi, S., Fujimori, H., Yamamoto, Y., & Yamamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001235200 · Cited by 425
Vlassara, H., Li, Y. M., Imani, F., Wojciechowicz, D., Yang, Z., Liu, F.-T., & Cerami, A. (1995) · Molecular Medicine · doi:10.1007/bf03401604 · Cited by 421
Self-citationDoi, T., Vlassara, H., Kirstein, M., Yamada, Y., Striker, G. E., & Striker, L. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2873 · Cited by 346
Self-citationLi, Y. M., Mitsuhashi, T., Wojciechowicz, D. C., Shimizu, N., Li, J., Stitt, A. W., He, C., Banerjee, D., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11047 · Cited by 338
Self-citationYeh, C.-H., Sturgis, L., Haidacher, J., Zhang, X.-N., Sherwood, S. J., Bjercke, R. J., Juhasz, O., Crow, M. T., Tilton, R. G., & Denner, L. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1495 · Cited by 326
The role of macrophages in diabetic glomerulosclerosis.
Furuta, T., Saito, T., Ootaka, T., Soma, J., Obara, K., Abe, K., & Yoshinaga, K. (1993) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80393-3 · Cited by 324
Vlassara, H., Brownlee, M., & Cerami, A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5588 · Cited by 310
Self-citationYamagishi, S., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M., & Makita, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202634200 · Cited by 308
The AGE‐receptor in the pathogenesis of diabetic complications
Vlassara, H. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.233 · Cited by 304
Self-citationAdvanced glycation end products up-regulate gene expression found in diabetic glomerular disease.
Yang, C., Vlassara, H., Peten, E. P., He, C., Striker, G. E., & Striker, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9436 · Cited by 293
Self-citationKislinger, T., Tanji, N., Wendt, T., Qu, W., Lu, Y., Ferran, L. J., Taguchi, A., Olson, K. E., Bucciarelli, L. G., Goova, M. T., et al. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.6.905 · Cited by 284
Ha, H., Yu, M. R., Choi, Y. J., Kitamura, M., & Lee, H. B. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134894 · Cited by 273
Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy
Banba, N., Nakamura, T., Matsumura, M., Kuroda, H., Hattori, Y., & Kasai, K. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00214.x · Cited by 268
Skolnik, E. Y., Yang, Z., Makita, Z., Radoff, S., Kirstein, M., & Vlassara, H. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.4.931 · Cited by 242
Self-citationCai, W., Gao, Q.-D., Zhu, L., Peppa, Μ., He, C., & Vlassara, H. (2002) · Molecular Medicine · doi:10.1007/bf03402014 · Cited by 236
Self-citationHuang, J., Guh, J., Chen, H., Hung, W., Lai, Y., & Chuang, L. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010401)81:1 · Cited by 226
Soulis, T., Thallas, V., Youssef, S., Gilbert, R. E., McWilliam, B. G., Cooper, M. E., & Murray‐McIntosh, R. P. (1997) · Diabetologia · doi:10.1007/s001250050725 · Cited by 220
AGEs induce oxidative stress and activate protein kinase C-βIIin neonatal mesangial cells
Scivittaro, V., Ganz, M. B., & Weiss, M. F. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f676 · Cited by 204
He, C., Sabol, J., Mitsuhashi, T., & Vlassara, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1308 · Cited by 191
Self-citationAccelerated diabetic glomerulopathy in galectin‐3/AGE receptor 3 knockout mice
Pugliese, G., Pricci, F., Iacobini, C., Leto, G., Amadio, L., Barsotti, P., Frigeri, L. G., Hsu, D. K., Vlassara, H., Liu, F., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0006com · Cited by 185
Self-citationActivation of nuclear factor-κB correlates with MCP-1 expression by human mesangial cells
Rovin, B. H., Dickerson, J. A., Tan, L. C., & Hébert, C. A. (1995) · Kidney International · doi:10.1038/ki.1995.410 · Cited by 179
Li, Y. M., Steffes, M. W., Donnelly, T. M., Liu, C., Fuh, H., Basgen, J. M., Bucala, R., & Vlassara, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3902 · Cited by 178
Self-citationFioretto, P., Steffes, M. W., Sutherland, D. E. R., & Mauer, M. S. (1995) · Kidney International · doi:10.1038/ki.1995.493 · Cited by 142
Role of oxidative stress in advanced glycation end product-induced mesangial cell activation.
Lal, M., Brismar, H., Eklöf, A., & Aperia, A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00367.x · Cited by 141
Scavenger Receptors that Recognize Advanced Glycation End Products
Miyazaki, A. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00171-8 · Cited by 113
Sioud, M. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.11.006 · Cited by 112
He, C., Koschinsky, T., Bünting, C. E., & Vlassara, H. (2001) · Molecular Medicine · doi:10.1007/bf03401949 · Cited by 93
Self-citationHe, C., Zheng, F., Stitt, A. W., Striker, L. J., Hattori, M., & Vlassara, H. (2000) · Kidney International · doi:10.1111/j.1523-1755.2000.00365.x · Cited by 83
Self-citationSatoh, H., Togo, M., Hara, M., Miyata, T., Han, K., Maekawa, H., Ohno, M., Hashimoto, Y., Kurokawa, K., & Watanabe, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7424 · Cited by 66
Iwashima, Y., Eto, M., Horiuchi, S., & Sano, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1539 · Cited by 53
Ribozyme Targeting of Receptor for Advanced Glycation End Products in Mouse Mesangial Cells
Tsuji, H., Iehara, N., Masegi, T., Imura, M., Ohkawa, J., Arai, H., Ishii, K., Kita, T., & Doi, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8489 · Cited by 49
Lynn, E. G., Siow, Y. L., Frohlich, J., Cheung, G. T. Y., & Karmin, O. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060002520.x · Cited by 35
Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis.
Cw, Y., Vlassara, H., Ge, S., & Lj, S. (1995) · PubMed · Cited by 29
Self-citationHisada, Y., Sakurai, H., & Sugaya, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2297 · Cited by 23
Arnalich‐Montiel, F., Hernánz, Á., López-Maderuelo, D., la Fuente, M. D., Arnalich‐Montiel, F., Andrés‐Mateos, E., Fernández‐Capitán, C., & Montiel, C. (2001) · Free Radical Research · doi:10.1080/10715760100301371 · Cited by 22
Research works printed but not linked: 2
- Yang, C. W., Vlassara, H., Striker, G. E. & Striker, L. J. (1995) Kidney Int. Suppl. 49, S55–S58.7674596
- Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D., Nowygrod, R., Neeper, M., Przysiecki, C., Shaw, A., et al. (1993) Am. J. Pathol. 143, 1699–1712.8256857
Cited by
Sorted by citations
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095
Metadata
- Authors
- Lu, C., He, J. C., Cai, W., Liu, H., Zhu, L., & Vlassara, H.
- Affiliations
- Mount Sinai Health System (US)
- Department of Geriatrics and Adult Development, Division of Experimental Diabetes and Aging, and Department of Medicine, Division of Nephrology, Mount Sinai School of Medicine, New York, NY 10029
- Corresponding author
- Vlassara, Helen
- ORCID
- Liu, Huixian
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-08-02
- Volume
- 101
- Issue
- 32
- Pages
- 11767-11772
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC511050
- OpenAlex
- W2030022427
- Cited by
- 228
- References
- 48
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 7 · 2021: 13 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 15 · 2016: 13 · 2015: 15 · 2014: 8 · 2013: 13 · 2012: 16
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK054788, DK54788)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- advanced glycation end products, receptor for advanced glycation end products, mesangial cells, diabetic nephropathy, inflammation, NF-κB signaling, kidney injury
- MeSH terms
- Receptor for Advanced Glycation End Products, Animals, Cell Line, Gene Expression Regulation, Glomerular Mesangium, Humans, Inflammation, Phosphorylation, Receptors, Immunologic, Transfection, Signal Transduction, NF-kappa B, Glycation End Products, Advanced, Chemokine CCL2, COS Cells, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
